Federal contract award

75H70524P00011

PROFICIENCY TESTING MATERIALS WITH CAP(COLLEGE OF AMERICAN PATHOLOGISTS) IN ORDER TO MEET COMPLIANCE STANDARDS FOR CLIA LICENSING AND DEPARTMENT ACCREDITATION THROUGH COLLEGE OF AMERICAN PATHOLOGISTS.

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeBEMIDJI AREA INDIAN HEALTH SERVICE
NAICS621511 — Medical Laboratories
PSCH966 — Other Quality Control, Testing and Inspection Services: Instruments and Laboratory Equipment
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeFIRM FIXED PRICE
Obligations$66.0K
Current contract value$66.0K
Potential contract value / ceiling$66.0K
Start dateNov 27, 2023
Current end dateDec 20, 2026
Potential end dateDec 20, 2028
Latest award activityMar 5, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 5 of 5 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Mar 5, 2026P00004$-460PROFICIENCY TESTING MATERIALS WITH CAP(COLLEGE OF AMERICAN PATHOLOGISTS) IN ORDER TO MEET COMPLIANCE STANDARDS FOR CLIA LICENSING AND DEPARTMENT ACCREDITATION THROUGH COLLEGE OF AMERICAN PATHOLOGISTS.
Oct 31, 2025P00003$18.8KPROFICIENCY TESTING MATERIALS WITH CAP(COLLEGE OF AMERICAN PATHOLOGISTS) IN ORDER TO MEET COMPLIANCE STANDARDS FOR CLIA LICENSING AND DEPARTMENT ACCREDITATION THROUGH COLLEGE OF AMERICAN PATHOLOGISTS.
Sep 11, 2025P00002$-162PROFICIENCY TESTING MATERIALS WITH CAP(COLLEGE OF AMERICAN PATHOLOGISTS) IN ORDER TO MEET COMPLIANCE STANDARDS FOR CLIA LICENSING AND DEPARTMENT ACCREDITATION THROUGH COLLEGE OF AMERICAN PATHOLOGISTS.
Nov 26, 2024P00001$25.0KPROFICIENCY TESTING MATERIALS WITH CAP(COLLEGE OF AMERICAN PATHOLOGISTS) IN ORDER TO MEET COMPLIANCE STANDARDS FOR CLIA LICENSING AND DEPARTMENT ACCREDITATION THROUGH COLLEGE OF AMERICAN PATHOLOGISTS.
Dec 19, 20230$22.7KPROFICIENCY TESTING MATERIALS WITH CAP(COLLEGE OF AMERICAN PATHOLOGISTS) IN ORDER TO MEET COMPLIANCE STANDARDS FOR CLIA LICENSING AND DEPARTMENT ACCREDITATION THROUGH COLLEGE OF AMERICAN PATHOLOGISTS.

Estimated positioning window

Dec 20, 2027 – Jun 20, 2028

Recompete signal:
45/100

Why this recompete signal

Contract timing and recorded acquisition signals at the time of calculation.

Stored score: 45/100. Available recorded signals: 40 points.

Contract end 2028-12-20 (780 days from calculation)
+15 points
1 historical awards in this buyer and category group
+0 points
5 recorded award transactions
+10 points
Latest award action: 2026-03-05
+5 points
Parent award identifier recorded
+0 points
Solicitation identifier recorded
+10 points
Linked official forecast
+0 points
Calculated on
2026-11-01 10:17:53.997580+00:00

The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.

Rule-based research score; it does not measure your chance of winning.

This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.

USAspending award record

. Rule-based research score; positioning dates are estimates.

Recompete score calculated Nov 1, 2026.

Buyer contacts from matching notices

Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.

ContactRolePublished contact methodsEvidenceSource date
De'Lana TangrenContactdelana.tangren@ihs.govSourceNov 28, 2023
Mary SimonContactMary.Simon2@ihs.govSourceNov 28, 2023

Research next steps

  1. Check the linked forecast or SAM for a confirmed solicitation and current timing.
  2. Verify whether remaining options may extend performance beyond the current end date.
  3. Check the stated set-aside against the solicitation and current certifications.
  4. Review the award scope and buyer evidence before making a bid/no-bid decision.